Pharmarise Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Pharmarise Holdings has a total shareholder equity of ¥7.4B and total debt of ¥12.3B, which brings its debt-to-equity ratio to 165.4%. Its total assets and total liabilities are ¥29.5B and ¥22.0B respectively. Pharmarise Holdings's EBIT is ¥908.0M making its interest coverage ratio 14. It has cash and short-term investments of ¥7.2B.
Key information
165.4%
Debt to equity ratio
JP¥12.31b
Debt
| Interest coverage ratio | 14x |
| Cash | JP¥7.15b |
| Equity | JP¥7.44b |
| Total liabilities | JP¥22.05b |
| Total assets | JP¥29.49b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 2796's short term assets (¥13.7B) exceed its short term liabilities (¥10.7B).
Long Term Liabilities: 2796's short term assets (¥13.7B) exceed its long term liabilities (¥11.4B).
Debt to Equity History and Analysis
Debt Level: 2796's net debt to equity ratio (69.3%) is considered high.
Reducing Debt: 2796's debt to equity ratio has reduced from 187.3% to 165.4% over the past 5 years.
Debt Coverage: 2796's debt is well covered by operating cash flow (22%).
Interest Coverage: 2796's interest payments on its debt are well covered by EBIT (14x coverage).